Before obtaining regulatory approval for the commercial distribution of our product candidates, we must conduct extensive preclinical tests and clinical trials to demonstrate the safety and efficacy in humans of our product candidates
Pierre-Louis: That said, the flip side, you know, these drugs are not a panacea, and we are finding some things that are maybe concerning
The only side effect is possible injection site irritation
I think when were also thinking about some of the more traditional recovery networks, we think about AA and NA, and there are definitely schools of thought within those camps that youre not really in recovery if you are using these medications
I may be a few minutes late on this, but I just saw this today and am so happy
Neurochem Int 128:94105 Davies M, Faerch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L et al (2021) Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
